Nuheara: Receives ethics approval to begin clinical trials

Nuheara Receives ethics approval to begin clinical trials

  • Nuheara (NUH) has received ethics approval from the Australian Hearing Human Research Ethics Committee (AHHREC) to commence its medical device clinical trial
  • The company has been working to develop multi-functional, personalised, intelligent hearing devices that augment a person’s hearing
  • The company said this supports its planned expansion into clinically tested and regulatory approved medical devices
  • The company Co-founder, Managing Director and CEO Justin Miller said National Acoustics Laboratories has now commenced recruiting for company’s medical device clinical trial
  • Recruitment has already begun for the trial, which the company says supports its planned expansion into clinically tested and regulatory approved medical devices
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

New York State Mandates Stores to Accept Cash Payments

New legislation aims to protect cash transactions across the state.Highlights: New law requires New York stores to accept...

PRA Issues £2 Million Penalty to Bank of London for Integrity Failures

Regulatory body penalizes the bank due to integrity shortcomings.Highlights: PRA fines Bank of London £2 million for integrity...

HSBC Appoints First Chief AI Officer, Strengthening AI Leadership

The bank aims to enhance its AI strategy and innovation.Highlights: HSBC names its first Chief AI Officer to...

Revolut Reports Surging Profits as Growth Accelerates

The financial technology firm sees significant profit increases in its latest report.Highlights: Revolut's profits surged significantly in the...